Dr. Samith T. Kochuparambil Joins Minnesota Oncology

Minnesota Oncology is pleased to announce the association of Samith T. Kochuparambil, M.D. with the practice of Medical Oncology & Hematology at the Minneapolis clinic beginning July 2015. 

“A diagnosis of cancer can be overwhelming for patients and their families, often signaling the beginning of a physical, emotional and spiritual journey," Dr. Kochuparambil said. "My goal is to empower my patients with accurate information, positive thinking and to provide state of the art care to help them through their journey with cancer. I strive to provide the most up-to-date treatments that incorporate breakthroughs in cancer therapies and access to latest clinical trials.” 

Dr. Kochuparambil received his medical degree from the Madras Medical College, Chennai, India. He completed a residency in Internal Medicine at the Medical College of Georgia in Augusta and a fellowship in Medical Oncology & Hematology at the Mayo Clinic, Rochester, MN.  

He is also co-author on a number of research articles in publications such as the International Journal of Oncology and American Journal of Medicine.

Appointments can be scheduled with Dr. Kochuparambil at the Minneapolis Clinic by calling (612) 884-6300 or at the Allina Outpatient Oncology Clinic in Buffalo, MN at (763) 684-6100.

Share

Categories

Tags

Recent Posts

#
June 3, 2025

Reflecting on her experience with Minnesota Oncology, Diane is filled with gratitude. “If you find yourself in the involuntary ‘cancer club,’ there is no better place to be than Minnesota Oncology.

#
May 28, 2025

This is the story about the origin of the Angel Foundation. Minnesota Oncology has long supported the Angel Foundation through sponsorships, employee-driven fundraisers, volunteerism, and payroll deduction. But many may not know why our two organizations are so close and how the foundation started.

#
May 19, 2025

Exposure to bacteria may contribute to rising rates of colorectal cancer in young adults. Colorectal cancer has moved from being the fourth leading of cause of cancer related death in both men and women under the age of 50 two decades ago to being number one in men and second in women.